drugset / Trial / NCT01365130
Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo Regimen
Phase 2
Terminated
15 enrolled
Howard Safran
Rhode Island Hospital · collabRoger Williams Medical Center · collabThe Miriam Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effectiveness of Cabazitaxel, as well as safety and side effects for patients with advanced gastroesophageal cancer
Timeline
- Start
- 2011-06
- Primary completion
- 2012-12
- Completion
- 2013-08
Outcome
Outcome not reported
Stopped (Enrollment): “As of 12/12/12 study closed to enrollment because study was determined to be ineffective.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cabazitaxel | Other / unclassified | 25 mg/m2 | Intravenous |